findmyKOL
Clinical trialNCT06052813Active, not recruitingPhase 1/PHASE2Interventional

A Study of BN104 in the Treatment of Acute Leukemia

SponsorInstitut de Recherches Internationales Servier (I.R.I.S.)Enrollment66ALL, AdultAML, AdultAcute LeukaemiaKMT2A RearrangementMenin InhibitorsNPM1 Mutation+1 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The Phase I/II trial is to learn the safety, pharmacokinetics, and preliminary efficacy of BN104 taken once daily or twice daily in patients with acute lymphocytic leukemia or acute myeloblastic leukemia.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • the First Affiliated Hospital of Soochow University

    Suzhou, China

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BN104 monotherapyBN104 monotherapy - rp2d
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
19 Oct 2023
Primary completion
31 Dec 2026
Completion
31 Dec 2027
Last update posted
25 Feb 2026
Registered enrollment
66
Registry id
NCT06052813

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.